Table 1.
ΔCT(MDH-gene) | ΔCT(MDH-gene) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Control | COX Inhibition |
P | Gene | Control | COX Inhibition |
P | ||||
mean | sd | mean | sd | mean | sd | mean | sd | ||||
Ca++ L-channels | Vasodilation | ||||||||||
CaLα1c | −2.33 | ±0.52 | −3.09 | ±0.31 | * | COX1 | −5.34 | ±0.37 | −5.29 | ±0.69 | |
CaLβ2 | −2.52 | ±0.34 | −3.26 | ±0.53 | * | COX2 | −5.53 | ±0.58 | −4.75 | ±0.89 | |
CaLβ3 | −2.71 | ±0.41 | −3.48 | ±0.52 | * | eNOS | −8.86 | ±0.91 | −9.68 | ±1.43 | |
EP2 | −8.16 | ±1.00 | −7.76 | ±0.36 | |||||||
K+ channels | EP3 | −5.46 | ±0.27 | −5.63 | ±0.62 | ||||||
BKCa | −9.34 | ±0.93 | −7.99 | ±1.31 | EP4 | −0.20 | ±1.20 | −0.71 | ±0.87 | ||
BKCaβ1 | −3.70 | ±0.52 | −4.30 | ±0.36 | * | HO1 | −3.52 | ±0.31 | −1.48 | ±0.97 | * |
Kir6.1 | −2.44 | ±0.72 | −3.52 | ±0.87 | * | HO2 | −2.51 | ±0.42 | −2.51 | ±0.28 | |
SUR2 | −3.21 | ±0.43 | −3.63 | ±0.61 | PDE1A | −5.22 | ±0.40 | −5.89 | ±0.19 | * | |
Kv1.2 | −4.68 | ±0.53 | −4.99 | ±0.76 | PDE1B | −2.52 | ±1.03 | −2.83 | ±0.48 | ||
Kv1.5 | −3.11 | ±0.36 | −3.99 | ±0.48 | * | PDE3A | −2.38 | ±0.28 | −3.41 | ±0.54 | * |
Kv2.1 | −3.53 | ±0.83 | −3.69 | ±0.71 | PDE3B | −2.80 | ±0.52 | −3.05 | ±0.13 | ||
Kv9.3 | −1.47 | ±0.41 | −2.18 | ±0.53 | PDE4D | −6.22 | ±0.69 | −6.51 | ±0.30 | ||
Kvβ1.2 | −3.96 | ±0.63 | −4.36 | ±0.36 | PDE5A | −2.75 | ±0.36 | −3.26 | ±0.55 | ||
Kvβ1.3 | −1.96 | ±0.36 | −2.29 | ±0.27 | |||||||
Remodeling | |||||||||||
Contractility | Ang−1 | −4.44 | ±0.54 | −4.76 | ±0.36 | ||||||
Caldesmon | −0.03 | ±0.21 | −0.76 | ±0.41 | * | Ang-2 | −5.91 | ±0.47 | −5.82 | ±0.74 | |
Calponin | −1.58 | ±0.55 | −2.01 | ±0.49 | ATIIR-1 | −4.96 | ±0.72 | −5.08 | ±0.45 | ||
Myocardin | −3.17 | ±0.38 | −3.97 | ±0.31 | * | HAS2 | −4.69 | ±0.45 | −4.99 | ±0.19 | |
MYH1 | 0.41 | ±0.68 | 0.05 | ±0.81 | HIF1α | −3.75 | ±0.87 | −3.99 | ±0.25 | ||
MYH2 | −1.97 | ±0.93 | −2.34 | ±0.48 | HIF2α | −2.71 | ±0.66 | −2.76 | ±0.44 | ||
RhoA | −0.94 | ±0.74 | −0.80 | ±0.44 | IFNγ | −3.07 | ±0.54 | −3.18 | ±0.25 | ||
RhoB | −2.36 | ±0.27 | −2.87 | ±0.51 | IL6 | −3.66 | ±0.37 | −4.06 | ±0.26 | ||
ROCK1 | −4.02 | ±0.81 | −4.27 | ±0.64 | PDGF-B | −5.06 | ±0.45 | −5.19 | ±0.54 | ||
NCX1 | −4.29 | ±0.95 | −4.92 | ±0.60 | Tenascin-C | −1.60 | ±0.30 | −2.13 | ±0.36 | * | |
PHLBN | −2.88 | ±0.68 | −2.98 | ±0.51 | TFAP2b | −4.81 | ±1.34 | −5.36 | ±1.05 | ||
SERCA3 | −6.58 | ±0.42 | −6.64 | ±0.23 | TGFβ1 | −4.17 | ±0.37 | −4.67 | ±0.29 | * | |
Tropomyosin | −3.00 | ±0.39 | −3.80 | ±0.54 | * | TGFβ3 | −2.71 | ±0.23 | −3.43 | ±0.21 | * |
TNFα | −2.38 | ±1.00 | −2.69 | ±0.29 | |||||||
Endothelin | TRAF1 | −5.96 | ±1.05 | −6.31 | ±0.53 | ||||||
ECE1 | −1.18 | ±0.68 | −1.86 | ±0.26 | VEGF | −3.57 | ±0.50 | −2.78 | ±0.42 | * | |
ET1 | −4.43 | ±0.95 | −4.55 | ±0.62 | |||||||
ETAr | −5.99 | ±1.52 | −6.27 | ±1.67 | |||||||
ETBr | −2.66 | ±0.79 | −2.77 | ±0.37 |
ΔCT(MDH-gene) = difference in cycle threshold (CT) between the expression of the housekeeping gene Malate dehydrogenase (MDH) and the gene of interest. Each unit of ΔCT(MDH-gene) represents a 2-fold increase in a gene’s mRNA. The more negative the ΔCT(MDH-gene), the fewer the number of starting copies of a gene (mRNA). Number of separate litters used: Control (day 19) = 9, COX-inhibition (days 15–19) = 7. From each litter of mice we obtained and pooled between 10–12 ductus.
p<0.05.
MYH, myosin heavy chain; ROCK1, Rho kinase 1; NCX1, Na+/Ca++ exchanger; PHLBN, phospholamban; SERCA, sarcoplasmic reticulum Ca++-ATPase; ECE, endothelin converting enzyme; ET, endothelin; ETAr, endothelin receptor A; eNOS, endothelial nitric oxide synthase; EP, prostaglandin E receptor; HO, heme oxygenase; PDE, phosphodiesterase; ang, angiopoietin; ATIIR-1, angiotensin II receptor; HAS, hyaluronic acid synthase; HIF, hypoxia inducible factor; IFN, interferon; IL, interleukin; PDGF, platelet derived growth factor.